🚨 Watchlist Update: Multiple Buy Levels Triggered

Two stocks from our Top 10 Breakout Watchlist this week have already touched their recommended buy levels intraday. Here’s a quick rundown:

Pegasystems Inc. (NASDAQ: PEGA) broke out of a multi-month downtrend channel and hit an intraday high of $37.31, briefly clearing our buy level of $37.00, before pulling back to close at $36.68.

The Kraft Heinz Company (NASDAQ: KHC) broke out of a flag pattern and touched an intraday high of $26.25, briefly pushing above our buy level of $25.90, before closing just fractionally below it at $25.87.

Bottom line: Both stocks are right at the door — watch for confirmed closes above the buy levels to validate the breakouts and set up entries. And now, on to today’s featured setup…

Comstock Resources, Inc. (NYSE: CRK) just broke out of a multi-month falling wedge on a +11.02% single-session surge — and looks headed even higher.

As we’ll get to just ahead, the combination of a transformative balance-sheet deal that could nearly halve the company’s debt load, a separate drilling partnership that funds growth without stock dilution, and a fresh technical breakout makes CRK one of the more interesting setups on the board. Here’s what’s going on…

The Themes Behind the Move

Comstock Resources is a U.S.-based independent energy company focused almost entirely on natural gas production from the Haynesville and Bossier shales — one of the largest and best-positioned dry-gas basins in North America, spanning roughly 1,069,991 acres across North Louisiana and East Texas, right in the corridor feeding the U.S. Gulf Coast’s LNG export terminals.

In plain English, Comstock drills the wells that produce the natural gas that gets liquefied at Gulf Coast terminals and shipped overseas — or piped to the fast-growing power plants supplying everything from Texas cities to the AI data-center buildout across the Southeast. Its business hinges on the price of Henry Hub natural gas, how efficiently it can bring new Haynesville wells online, and how well it manages its balance sheet through the cash-intensive early years of expanding its Western Haynesville footprint.

CRK’s latest move reflects a powerful confluence of developments — financial, operational, and strategic — that have come together in rapid succession to fundamentally reframe the company’s near-term trajectory.

Theme / Catalyst What Happened Why Traders Care
$1.65B SOCAR strategic partnership On September 1, 2026, Comstock announced a $1.65 billion cash LOI with SOCAR (Azerbaijan’s state oil company) for minority, non-operated stakes in Comstock’s Legacy Haynesville (20%), Western Haynesville (15%), and its 73% Pinnacle midstream position (15%). Definitive PSA is targeted by Oct 31, 2026, with close expected by year-end. Pro forma net debt would drop from ~$3.1B to ~$1.5B. Comstock keeps operatorship. This is the re-rating catalyst. Nearly halving net debt in one stroke solves the company’s biggest overhang and validates asset value after a weak year. On top of that, SOCAR brings international LNG marketing optionality — a strategic bonus on top of the pure balance-sheet fix.
$450M Jerry Jones drilling JV — already in force Separately, a partnership led by Dallas Cowboys owner Jerry Jones (Comstock’s majority shareholder) will fund ~$450 million across 27 wells starting Sept 1, 2026 — carrying 85% of costs on 18 Western Haynesville wells and 80% on 9 Legacy wells over the next 12 months. After a 15% ROI hurdle, half the interest reverts to Comstock. Unlike the SOCAR LOI, this deal is already in force. The Jones carry offloads a huge chunk of near-term drilling costs so Comstock can keep expanding its high-return Western Haynesville acreage without burning cash or issuing stock. It’s also a strong signal of alignment — the controlling shareholder is putting fresh capital in, not pulling it out.
Sector tailwinds — Gulf Coast LNG + power demand U.S. LNG exports were up ~23% in H1 2026 as Golden Pass and other terminals ramped, and the Haynesville sits geographically as the swing supply basin for Gulf Coast LNG and fast-growing Gulf power demand. Comstock has also selected a Western Haynesville site for a dedicated power-generation hub — a direct play on the Texas/Louisiana AI data-center buildout. CRK is one of the cleanest pure-play vehicles for Gulf Coast LNG and Southeast power growth. As new export capacity absorbs supply and data-center demand pushes power load higher, Haynesville producers with premium acreage get direct pricing leverage — with the AI/power-hub angle layering optionality on top of the core gas thesis.
Fundamentals + prior Sixth Street deleveraging Q2 production hit 113.1 Bcfe (+16% QoQ) on total revenue of $353.3M, with adjusted EBITDAX of ~$245M. Liquidity sits at ~$1.2B. Recent Western Haynesville wells averaged initial production rates of 29–30 MMcf/day on long laterals. The SOCAR deal builds on June 2026’s $600M Sixth Street investment in Pinnacle, which already retired Pinnacle debt while Comstock kept 73% and control. Volumes are growing, Western Haynesville is proving out premium inventory, and the balance-sheet playbook is now clearly working — Sixth Street was step one, SOCAR is step two. Layered together, they turn a leveraged E&P into a much cleaner story with real asset-monetization credibility.
Analyst coverage — Street playing catch-up Among the 10 analysts covering CRK, the average twelve-month price target sits at $15.11, with a high target of $24.00 — roughly 50% upside from current levels at the top end. On September 1, Mizuho raised its target from $19 to $20 (Neutral) — the first post-deal action to catch up with the SOCAR announcement. Bank of America maintains a $24.00 Neutral target, marking the top of the range. The stock has now raced past the older $15.11 average, but that average was set before the SOCAR deal fundamentally changed the balance-sheet picture. Mizuho’s same-day raise is a signal — the coverage universe is only starting to reprice for a company with nearly half its net debt about to disappear. Expect the average to work higher.
Market conviction signal The breakout came on a +11.02% single-session surge on 11.25 million shares — the tallest volume bar on the chart. CRK cleared the upper boundary of a multi-month falling wedge and pushed decisively back above its 50-day moving average in the same session. The move was driven by two concrete, hard-news catalysts landing on the same day rather than by momentum-chasing flow. When a stock decisively clears a multi-month consolidation on the tallest volume bar in months — on the same day two hard-news catalysts land — that’s the kind of tape signal that suggests institutional money is buying conviction, not chasing momentum. It’s the difference between a headline pop and the start of a re-rating.
Upcoming triggers Traders are watching the SOCAR definitive PSA target date of October 31, 2026, Q3 2026 earnings around November 2, 2026 (consensus ~$0.06 EPS, ~$450–458M revenue), year-end 2026 target close of the SOCAR transaction, ongoing Western Haynesville well results and turn-in-lines, gas strip pricing into winter 2026/27, and any power-hub offtake news tied to the AI/data-center angle. A tightly staggered set of hard-date catalysts — the PSA milestone, Q3 earnings, the year-end close, and ongoing operational prints — each capable of independently moving the stock through Q4 2026 and into 2027. This is exactly the kind of event-rich window that supports a defined-catalyst trade.

If needed, swipe or scroll sideways to view the full table.

Put it all together, and CRK is looking less like a struggling, high-debt natural-gas producer treading water below its 200-day moving average and more like a company on the verge of a balance-sheet reset — with strategic capital lined up, drilling partnerships already flowing, and premium Haynesville acreage sitting right in the path of Gulf Coast LNG expansion.

The story is getting stronger, but the chart is what could determine whether this move has more room to run in the near term. Here are the bullish technical signals traders should be watching now.

Bullish Technical Signals

#1 Falling Wedge Pattern Breakout (Daily): CRK has broken out of a multi-month falling wedge — the converging downward-sloping trendlines marked in purple on the daily chart. A falling wedge is a bullish structure by nature: each successive low is met by buyers at progressively less-negative angles, which tells you selling pressure is drying up rather than intensifying. Price has now closed decisively through the upper boundary at $16.02, a +11.02% single-session move, and — critically — it did so on a clear volume surge (11.25M, the tallest bar on the chart). Volume is the tell here: it confirms real participation behind the break rather than a low-conviction drift through the line, and it marks the wedge’s typical “final shakeout” giving way to a fresh bullish leg. This is the structural trigger the rest of the signals build on.

CRK stock daily chart showing falling wedge breakout on high volume

CRK – Daily Chart

#2 Price Above the 50-Day SMA (Daily): CRK is trading at $16.02, back above its 50-day SMA ($13.74) after the breakout — a reclaim that flips the near-term trend in the bulls’ favor and turns that rising average into a dynamic support shelf on any retest. The honest nuance worth owning: this is not full golden-cross alignment yet. The 50-day ($13.74) still sits below the 200-day ($18.21), and price itself remains under that longer average, so the $18.21 line stands as the next meaningful overhead the move has to clear before the daily structure is unambiguously bullish. For now, the reclaim gives buyers a defined floor to lean on while the breakout matures — a first hurdle cleared, not the last.

#3 Bullish ADX and DI (Daily): The directional read is firmly bullish — +DI (37.48) towers over –DI (10.80), leaving no ambiguity about who controls trend direction. What elevates this from good to high-quality is the ADX line itself: at 24.15 it’s rising from a suppressed base beneath both DI lines toward +DI, and it sits just under the 25 threshold that separates trend from chop. That specific configuration — bulls in directional command while ADX inflects up from a low base — is the textbook signature of a new trend gaining force rather than a mature one running out of road. In practical terms, the trend is in its early innings with runway still ahead, which is exactly what you want to see confirming a fresh breakout.

#4 Bullish Aroon (Daily): Aroon Up is pinned at 100.00 while Aroon Down sits down at 21.43 — the cleanest bullish configuration the indicator produces. Aroon Up at its ceiling means CRK logged a fresh high within the lookback window in the very recent past, which is precisely consistent with today’s wedge breakout, while the depressed Aroon Down shows sellers have simply gone quiet. The wide separation between the two lines points to one-sided participation — buyers active, sellers absent — and reinforces that this is a decisive move, not a coin-flip. Stacked against the breakout in #1, both reads point the same direction.

#5 Above Support Area, Price Above the 200-Week SMA (Weekly): Zooming out, the weekly chart shows CRK holding above a resistance-turned-support level — the pink dotted line at roughly $13.07 — and reclaiming its 200-week SMA ($14.81), with price at $16.02 sitting comfortably above both. Levels that successfully invert roles are the ones the market respects, and having that support shelf confirmed by the rising 200-week gives the longer-term structure a genuine floor. The tension to name: the 50-week SMA ($18.54) is overhead resistance, and it clusters almost exactly with the daily 200-day ($18.21) — so the $18.2–$18.5 zone is the first real supply the breakout must absorb, sitting well below PT1 at $23. When the daily wedge breakout and the weekly reclaim of support and the 200-week line agree like this, the signal carries more weight than either timeframe alone.

CRK stock weekly chart showing support reclaim and bullish MACD

CRK – Weekly Chart

#6 Bullish MACD (Weekly): On the weekly, the MACD line (–1.13) has crossed above its signal line (–1.56), pushing the histogram positive (+0.43) — a fresh bullish momentum crossover on the higher timeframe, where these signals carry far more weight than on the daily. The nuance worth stating plainly: the cross is happening below the zero line, so it marks momentum turning up from a low base rather than a fully matured uptrend. That’s actually the higher-reward spot — it catches the turn early — with full confirmation coming on a move above zero, where weekly momentum decisively flips positive. Right now the signal is early and improving, which fits a breakout that’s only just underway.

#7 Bullish RSI (Weekly): The weekly RSI reads 51.67 — above the 50 midline that divides bullish from bearish momentum — and it’s turning up above its own signal average at 40.37. This is a two-part read: the cross back above 50 marks the momentum handoff to buyers, while the upslope confirms that momentum is expanding rather than stalling. Just as important, at 51.67 there’s ample runway before the overbought 70 zone becomes a headwind — the move is gaining strength, not stretched. On the weekly timeframe this is a durable, structural read, and it lines up with the weekly MACD in #6 to give the higher timeframe two independent momentum confirmations.

Risks to Consider

Even strong setups can fail, especially in a leveraged, commodity-sensitive natural-gas producer like Comstock. A few things could knock the stock off course:

  • A close back below the falling wedge’s upper trendline or a decisive break of the $13.07 weekly support area on heavy volume would invalidate the breakout thesis
  • Negative company-specific news or broader market weakness — any sector rotation out of energy or a broader risk-off move would pressure the entire natural-gas E&P group
  • Natural gas price volatility — CRK’s cash flow is highly leveraged to Henry Hub prices, and a sustained slide back toward the $2.50–$3.00 range would erode margins even as production grows
  • Elevated debt and negative free cash flow — long-term debt stands at ~$3.1 billion and Q2 FCF ran an estimated ~–$223 million; the pro forma cut to ~$1.5 billion only materializes if the SOCAR transaction actually closes
  • The SOCAR deal is currently only an LOI — no cash changes hands until a definitive purchase agreement is signed by Oct 31, 2026 and the transaction closes by year-end, leaving regulatory, third-party, and negotiation risk that could delay, resize, or unwind the deal
  • Valuation vs. Street — the stock now trades above the average analyst target of $15.11, and Q2 volume growth came alongside soft realized prices, leaving limited margin of safety at current levels until analysts refresh their models for the new deal picture
  • Concentration and execution risk — the asset base is almost entirely Haynesville/Bossier, and the deeper, hotter Western Haynesville wells showed some efficiency issues in Q2
  • Insider and governance concentration — the Jones-family JV creates useful alignment but also deepens the majority holder’s influence, and related-party dynamics warrant ongoing monitoring

The Bottom Line

CRK is breaking out of a multi-month falling wedge on the daily chart while reclaiming its 200-week SMA and holding above a key resistance-turned-support level on the weekly — a dual-timeframe technical setup that historically signals the start of a sustained move higher.

The fundamental story underneath the chart is just as strong: a $1.65 billion SOCAR partnership set to slash net debt nearly in half, a separate $450 million Jerry Jones-family drilling JV already funding 27 wells starting September 1, and premium Haynesville acreage strategically positioned near booming Gulf Coast LNG exports.

Combine that with multiple hard-date catalysts staggered through the next several months — Mizuho’s fresh price-target raise, the October 31 SOCAR PSA milestone, Q3 earnings in early November, and the year-end deal close — and CRK looks like one of the more compelling risk-reward setups on the board right now.

If this is a trade you want to get in on, here’s how we’d play it. Below you’ll find our exact entry level, both price targets that imply 39%–64% potential upside, and the stop-loss we’re using to manage the downside.

Recommended Trade Setup

Item Detail
Buy Level Above approximately $16.50
Price Target 1 $23.00 — Potential upside: 39%
Price Target 2 $27.00 — Potential upside: 64%
Timeframe Next 3–6 months
Stop-Loss $13.00 on a closing basis
Trade Invalidation Void if price hits stop-loss before entry triggers

If needed, swipe or scroll sideways to view the full table.

For a risk of approximately $3.50 per share, the target rewards are about $6.50 and $10.50 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.

Note on Trade Invalidation: This recommendation stays active as long as the technical structure holds. If CRK drops to or below the $13.00 stop-loss before the $16.50 entry triggers, the trade is automatically void — the support underpinning the thesis would have broken, and the risk-reward setup would no longer justify entry.

Happy Trading!
Tara and Greg

🥈 Almost Made the Cut

Today’s featured trade, Comstock Resources, Inc. (NYSE: CRK), was our top pick of several breakout candidates we evaluated. The following two stocks were strong candidates that made it to the final round — they came up just short of the top spot, but remain on our watchlist and could be featured soon:

MiniMed Group, Inc. (NASDAQ: MMED) — The diabetes-technology company is benefiting from accelerating revenue growth, raised full-year guidance, and the commercial rollout of its MiniMed Flex insulin pump paired with Abbott’s Instinct continuous glucose monitor, with expanded Medicare reimbursement adding further support; however, with shares already trading near their 52-week high following a sharp earnings-driven move, a pullback toward the $21–$22 breakout zone would likely offer a more attractive risk-adjusted entry.

Vaxcyte, Inc. (NASDAQ: PCVX) — The clinical-stage vaccine developer is approaching a potentially transformative Q4 2026 Phase 3 readout for VAX-31, its investigational 31-valent pneumococcal vaccine, backed by a $2.5 billion cash position and a weekly setup positioned above key moving averages; even so, the binary nature of the upcoming clinical results makes PCVX a higher-risk proposition than CRK, notwithstanding its exceptional theoretical path toward the $88–$90 resistance area.